Ozempic (semaglutide)

Diabetes obesity weight loss
Biotech

Lilly triple-G bet sees 16.8% weight loss in ph. 3 diabetes test

Eli Lilly is rounding out its pitch for retatrutide with new data looking at blood sugar reductions and weight loss in patients with Type 2 diabetes.
Fraiser Kansteiner Mar 19, 2026 6:45am
Dark and dramatic sky with sunlight

Skye links CB1-Wegovy combo to 22.3% weight loss after a year

Feb 2, 2026 8:08am
weight loss scale weigh measure tape obesity overweight

Lilly rounds out orforglipron data ahead of obesity filings

Sep 17, 2025 9:00am
Yellow tape measure with a variety of weight loss medication on blue background

Lilly's oral GLP-1 tied to 12% weight loss in phase 3 trial

Aug 7, 2025 6:30am
Doustdar
Favicon Fierce Pharma

Novo Nordisk names new CEO as it cuts sales, profit outlook

Jul 29, 2025 10:10am
Novo Nordisk CEO
Favicon Fierce Pharma

Novo's longtime CEO Lars Fruergaard Jørgensen to step down

May 16, 2025 9:41am